Zions Bancorporation’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $22.1K | Hold |
31
| – | – | ﹤0.01% | 498 |
|
|
2024
Q3 | $32.6K | Sell |
31
-6
| -16% | -$6.68K | ﹤0.01% | 466 |
|
|
2024
Q2 | $38.9K | Sell |
37
-7
| -16% | -$6.79K | ﹤0.01% | 459 |
|
|
2024
Q1 | $42.4K | Sell |
44
-6
| -12% | -$5.71K | ﹤0.01% | 444 |
|
|
2023
Q4 | $43.9K | Sell |
50
-2
| -4% | -$1.65K | ﹤0.01% | 431 |
|
|
2023
Q3 | $42.8K | Hold |
52
| – | – | ﹤0.01% | 406 |
|
|
2023
Q2 | $37.4K | Hold |
52
| – | – | ﹤0.01% | 430 |
|
|
2023
Q1 | $42.7K | Sell |
52
-4
| -7% | -$3.02K | ﹤0.01% | 437 |
|
|
2022
Q4 | $40.4K | Buy |
56
+4
| +8% | +$2.95K | ﹤0.01% | 470 |
|
|
2022
Q3 | $36K | Buy |
52
+6
| +13% | +$3.78K | ﹤0.01% | 469 |
|
|
2022
Q2 | $27K | Sell |
46
-21
| -31% | -$13.7K | ﹤0.01% | 558 |
|
|
2022
Q1 | $47K | Buy |
67
+12
| +22% | +$7.59K | ﹤0.01% | 521 |
|
|
2021
Q4 | $35K | Buy |
55
+13
| +31% | +$7.99K | ﹤0.01% | 520 |
|
|
2021
Q3 | $25K | Buy |
42
+2
| +5% | +$1.24K | ﹤0.01% | 574 |
|
|
2021
Q2 | $22K | Sell |
40
-15
| -27% | -$7.6K | ﹤0.01% | 568 |
|
|
2021
Q1 | $26K | Buy |
55
+22
| +67% | +$10.7K | ﹤0.01% | 535 |
|
|
2020
Q4 | $16K | Buy |
33
+3
| +10% | +$1.62K | ﹤0.01% | 594 |
|
|
2020
Q3 | $17K | Buy |
30
+3
| +11% | +$1.82K | ﹤0.01% | 572 |
|
|
2020
Q2 | $17K | Buy |
27
+18
| +200% | +$10.2K | ﹤0.01% | 530 |
|
|
2020
Q1 | $4K | Sell |
9
-4
| -31% | -$1.65K | ﹤0.01% | 738 |
|
|
2019
Q4 | $5K | Sell |
13
-32
| -71% | -$10.8K | ﹤0.01% | 799 |
|
|
2019
Q3 | $12K | Buy |
45
+15
| +50% | +$4.44K | ﹤0.01% | 680 |
|
|
2019
Q2 | $9K | Sell |
30
-11
| -27% | -$3.66K | ﹤0.01% | 671 |
|
|
2019
Q1 | $17K | Sell |
41
-328
| -89% | -$135K | ﹤0.01% | 598 |
|
|
2018
Q4 | $138K | Buy |
369
+280
| +315% | +$102K | 0.1% | 104 |
|
|
2018
Q3 | $36K | Buy |
89
+38
| +75% | +$14.5K | 0.01% | 382 |
|
|
2018
Q2 | $18K | Buy |
+51
| New | +$15.9K | 0.01% | 289 |
|
|
2017
Q4 | – | Sell |
-112
| Closed | -$50K | – | 904 |
|
|
2017
Q3 | $50K | Buy |
112
+90
| +409% | +$42.8K | 0.01% | 570 |
|
|
2017
Q2 | $11K | Sell |
22
-10
| -31% | -$4.38K | ﹤0.01% | 334 |
|
|
2017
Q1 | $12K | Sell |
32
-22
| -41% | -$8.15K | ﹤0.01% | 346 |
|
|
2016
Q4 | $20K | Buy |
54
+26
| +93% | +$9.89K | ﹤0.01% | 382 |
|
|
2016
Q3 | $11K | Buy |
28
+7
| +33% | +$2.81K | ﹤0.01% | 476 |
|
|
2016
Q2 | $8K | Hold |
21
| – | – | ﹤0.01% | 487 |
|
|
2016
Q1 | $8K | Sell |
21
-8
| -28% | -$3.3K | ﹤0.01% | 568 |
|
|
2015
Q4 | $12K | Sell |
29
-3
| -9% | -$1.63K | ﹤0.01% | 453 |
|
|
2015
Q3 | $18K | Buy |
+32
| New | +$17.2K | ﹤0.01% | 384 |
|
|
2015
Q2 | – | Sell |
-21
| Closed | -$9K | – | 629 |
|
|
2015
Q1 | $9K | Buy |
+21
| New | +$8.9K | ﹤0.01% | 549 |
|
Other funds holding REGN
Zions Bancorporation's REGN Position: Q4 2024 in Review
Zions Bancorporation held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2024 at 31 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #498.
Zions Bancorporation first reported a position in REGN in Q1 2015 and has held it in 37 quarters since. The position peaked at $138K in Q4 2018. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.
- Zions Bancorporation held 31 shares of Regeneron Pharmaceuticals worth $22.1K as of Q4 2024.
- Zions Bancorporation left its Regeneron Pharmaceuticals share count unchanged in Q4 2024.
- Regeneron Pharmaceuticals made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #498 holding.
- Zions Bancorporation first reported a position in Regeneron Pharmaceuticals in Q1 2015 and has held it in 37 quarters since.
- Zions Bancorporation's Regeneron Pharmaceuticals position peaked at $138K in Q4 2018.
- 1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.